KEGG Orthology (KO)

[ Brite menu | Organism menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Metabolism
 
 Genetic Information Processing
 
 Environmental Information Processing
 
 Cellular Processes
 
   Transport and catabolism
 
   Cell motility
 
   Cell growth and death
     04110 Cell cycle [PATH:ko04110]
     04111 Cell cycle - yeast [PATH:ko04111]
     04112 Cell cycle - Caulobacter [PATH:ko04112]
     04113 Meiosis - yeast [PATH:ko04113]
     04114 Oocyte meiosis [PATH:ko04114]
     04210 Apoptosis [PATH:ko04210]
       K04721  TNFSF10, TRAIL; tumor necrosis factor ligand superfamily member 10
       K04722  TNFRSF10, TRAILR; tumor necrosis factor receptor superfamily member 10
       K04389  TNFSF6, FASL; tumor necrosis factor ligand superfamily member 6
       K04390  TNFRSF6, FAS; tumor necrosis factor receptor superfamily member 6
       K02373  FADD; FAS-associated death domain protein
       K03156  TNFA; tumor necrosis factor superfamily, member 2
       K03158  TNFRSF1A, TNFR1; tumor necrosis factor receptor superfamily member 1A
       K03171  TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
       K04724  CFLAR, FLIP; CASP8 and FADD-like apoptosis regulator
       K04398  CASP8; caspase 8 [EC:3.4.22.61]
       K04400  CASP10; caspase 10 [EC:3.4.22.63]
       K04396  CASP6; caspase 6 [EC:3.4.22.59]
       K02187  CASP3; caspase 3 [EC:3.4.22.56]
       K04397  CASP7; caspase 7 [EC:3.4.22.60]
       K04726  BID; BH3 interacting domain death agonist
       K02159  BAX; apoptosis regulator BAX
       K14021  BAK, BAK1; Bcl-2 homologous antagonist/killer
       K10522  DIABLO, SMAC; diablo
       K16943  SEPT4; septin 4
       K08669  HTRA2, PRSS25; HtrA serine peptidase 2 [EC:3.4.21.108]
       K08738  CYC; cytochrome c
       K02084  APAF1; apoptotic protease-activating factor
       K04399  CASP9; caspase 9 [EC:3.4.22.62]
       K07818  PRF1; perforin 1
       K01353  GZMB; granzyme B [EC:3.4.21.79]
       K07374  TUBA; tubulin alpha
       K02539  MCL1; myeloid leukemia cell differntiation protein MCL-1
       K05692  ACTB_G1; actin beta/gamma 1
       K06114  SPTA; spectrin alpha
       K12641  LMNA; lamin A/C
       K07611  LMNB; lamin B
       K10798  PARP; poly [ADP-ribose] polymerase [EC:2.4.2.30]
       K02310  DFFA, DFF45; DNA fragmentation factor, 45 kD, alpha subunit
       K02311  DFFB, DFF40; DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-]
       K01173  ENDOG; endonuclease G, mitochondrial
       K04727  PDCD8, AIF; programmed cell death 8 (apoptosis-inducing factor) [EC:1.-.-.-]
       K08852  ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [EC:2.7.11.1 3.1.26.-]
       K03173  TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
       K04958  ITPR1; inositol 1,4,5-triphosphate receptor type 1
       K04959  ITPR2; inositol 1,4,5-triphosphate receptor type 2
       K04960  ITPR3; inositol 1,4,5-triphosphate receptor type 3
       K01367  CAPN1; calpain-1 [EC:3.4.22.52]
       K03853  CAPN2; calpain-2 [EC:3.4.22.53]
       K04741  CASP12; caspase 12 [EC:3.4.22.-]
       K08860  EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 [EC:2.7.11.1]
       K03237  EIF2S1; translation initiation factor 2 subunit 1
       K04374  ATF4, CREB2; cyclic AMP-dependent transcription factor ATF-4
       K04452  DDIT3, GADD153; DNA damage-inducible transcript 3
       K01363  CTSB; cathepsin B [EC:3.4.22.1]
       K01275  CTSC; cathepsin C [EC:3.4.14.1]
       K01379  CTSD; cathepsin D [EC:3.4.23.5]
       K01373  CTSF; cathepsin F [EC:3.4.22.41]
       K01366  CTSH; cathepsin H [EC:3.4.22.16]
       K01371  CTSK; cathepsin K [EC:3.4.22.38]
       K01365  CTSL; cathepsin L [EC:3.4.22.15]
       K01374  CTSO; cathepsin O [EC:3.4.22.42]
       K01368  CTSS; cathepsin S [EC:3.4.22.27]
       K01375  CTSL2, CTSV; cathepsin V [EC:3.4.22.43]
       K08569  CTSW; cathepsin W [EC:3.4.22.-]
       K08568  CTSZ; cathepsin X [EC:3.4.18.1]
       K16060  BIRC2_3; baculoviral IAP repeat-containing protein 2/3
       K04725  XIAP, BIRC4; E3 ubiquitin-protein ligase XIAP [EC:2.3.2.27]
       K08731  BIRC5; baculoviral IAP repeat-containing protein 5
       K16341  BCL2L11, BIM; Bcl-2-like protein 11
       K04570  BCL2L1, bcl-xL; Bcl-2-like 1 (apoptosis regulator Bcl-X)
       K02161  BCL2; apoptosis regulator Bcl-2
       K02308  DAXX; death-associated protein 6
       K02861  RIPK1, RIP1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
       K19901  DAB2IP, AIP1; disabled homolog 2-interacting protein
       K04426  MAP3K5, ASK1; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
       K04440  JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
       K02158  BAD; Bcl-2-antagonist of cell death
       K04448  JUN; transcription factor AP-1
       K04379  FOS; proto-oncogene protein c-fos
       K04451  TP53, P53; tumor protein p53
       K02512  HRK; activator of apoptosis harakiri
       K04466  MAP3K14, NIK; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
       K04467  IKBKA, IKKA, CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
       K07209  IKBKB, IKKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
       K07210  IKBKG, IKKG, NEMO; inhibitor of nuclear factor kappa-B kinase subunit gamma
       K04734  NFKBIA; NF-kappa-B inhibitor alpha
       K02580  NFKB1; nuclear factor NF-kappa-B p105 subunit
       K04735  RELA; transcription factor p65
       K02374  PTPN13, FAP-1; tyrosine-protein phosphatase non-receptor type 13
       K04402  GADD45; growth arrest and DNA-damage-inducible protein
       K03172  TRAF1; TNF receptor-associated factor 1
       K02162  BCL2A1; hematopoietic Bcl-2-related protein A1
       K04728  ATM, TEL1; ataxia telangiectasia mutated family protein [EC:2.7.11.1]
       K10130  LRDD, PIDD; leucine-rich repeats and death domain-containing protein
       K13773  TP53AIP1; p53-regulated apoptosis-inducing protein 1
       K10132  BBC3, PUMA; Bcl-2-binding component 3
       K10131  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1
       K02186  CASP2; caspase 2 [EC:3.4.22.55]
       K02582  NGFB; nerve growth factor, beta
       K03176  NTRK1, TRKA; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
       K04736  IL3; interleukin 3
       K04737  IL3RA; interleukin 3 receptor alpha
       K04738  CSF2RB, IL3RB; cytokine receptor common subunit beta
       K00922  PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
       K02649  PIK3R; phosphoinositide-3-kinase, regulatory subunit
       K06276  PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
       K04456  AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
       K02833  HRAS; GTPase HRas
       K07827  KRAS, KRAS2; GTPase KRas
       K07828  NRAS; GTPase NRas
       K04366  RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
       K04368  MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
       K04369  MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
       K04371  MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
     04214 Apoptosis - fly [PATH:ko04214]
     04215 Apoptosis - multiple species [PATH:ko04215]
     04115 p53 signaling pathway [PATH:ko04115]
 
   Cellular commiunity
 
 Organismal Systems
 
   Immune system
     04640 Hematopoietic cell lineage [PATH:ko04640]
     04610 Complement and coagulation cascades [PATH:ko04610]
     04611 Platelet activation [PATH:ko04611]
     04620 Toll-like receptor signaling pathway [PATH:ko04620]
     04621 NOD-like receptor signaling pathway [PATH:ko04621]
     04622 RIG-I-like receptor signaling pathway [PATH:ko04622]
     04623 Cytosolic DNA-sensing pathway [PATH:ko04623]
     04650 Natural killer cell mediated cytotoxicity [PATH:ko04650]
       K06751  MHC1; major histocompatibility complex, class I
       K07980  KIR3DL; killer cell immunoglobulin-like receptor 3DL
       K07981  KIR2DL; killer cell immunoglobulin-like receptor 2DL
       K06541  KLRC; killer cell lectin-like receptor subfamily C
       K06516  KLRD1, CD94; killer cell lectin-like receptor subfamily D member 1
       K05697  PTPN6, SHP-1; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
       K07293  PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
       K06490  ICAM1; intercellular adhesion molecule 1
       K06523  ICAM2; intercellular adhesion molecule 2
       K05718  ITGAL; integrin alpha L
       K06464  ITGB2; integrin beta 2
       K05871  PTK2B, FAK2; focal adhesion kinase 2 [EC:2.7.10.2]
       K05730  VAV; guanine nucleotide exchange factor VAV
       K04392  RAC1; Ras-related C3 botulinum toxin substrate 1
       K07860  RAC2; Ras-related C3 botulinum toxin substrate 2
       K07861  RAC3; Ras-related C3 botulinum toxin substrate 3
       K04409  PAK1; p21-activated kinase 1 [EC:2.7.11.1]
       K04368  MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
       K04369  MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
       K04371  MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
       K03156  TNFA; tumor necrosis factor superfamily, member 2
       K05427  CSF2, GMCSF; granulocyte-macrophage colony-stimulating factor
       K04687  IFNG; interferon gamma
       K07982  KIR2DS; killer cell immunoglobulin-like receptor 2DS
       K06742  NCR2; natural cytotoxicity triggering receptor 2
       K07992  TYROBP, DAP12; TYRO protein tyrosine kinase binding protein
       K05856  LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
       K06856  IGH; immunoglobulin heavy chain
       K06463  FCGR3, CD16; low affinity immunoglobulin gamma Fc region receptor III
       K06741  NCR1; natural cytotoxicity triggering receptor 1
       K06743  NCR3; natural cytotoxicity triggering receptor 3
       K07983  FCER1G; Fc receptor, IgE, high affinity I, gamma polypeptide
       K06453  CD3Z; CD3Z antigen, zeta polypeptide
       K07360  ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
       K05855  SYK; spleen tyrosine kinase [EC:2.7.10.2]
       K07361  LCP2; lymphocyte cytosolic protein 2
       K07362  LAT; linker for activation of T cells
       K01116  PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
       K05859  PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
       K07984  SH3BP2; SH3-domain binding protein 2
       K00922  PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
       K02649  PIK3R; phosphoinositide-3-kinase, regulatory subunit
       K05703  FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
       K06279  SHC1; SHC-transforming protein 1
       K17447  SHC2; SHC-transforming protein 2
       K17448  SHC3; SHC-transforming protein 3
       K17449  SHC4; SHC-transforming protein 4
       K04364  GRB2; growth factor receptor-binding protein 2
       K03099  SOS; son of sevenless
       K02833  HRAS; GTPase HRas
       K07827  KRAS, KRAS2; GTPase KRas
       K07828  NRAS; GTPase NRas
       K08845  ARAF, ARAF1; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
       K04365  BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
       K04366  RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
       K07985  MIC; MHC class I-related protein
       K07986  ULBP; UL16 binding protein
       K07987  RAET1; retinoic acid early transcript 1
       K06728  KLRK1; killer cell lectin-like receptor subfamily K member 1
       K07988  HCST, DAP10; hematopoietic cell signal transducer
       K06479  CD48, BCM1; CD48 antigen
       K06582  CD244; natural killer cell receptor 2B4
       K04348  PPP3C, CNA; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
       K06268  PPP3R, CNB; serine/threonine-protein phosphatase 2B regulatory subunit
       K04446  NFATC1, NFAT2, NFATC; nuclear factor of activated T-cells, cytoplasmic 1
       K17332  NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic 2
       K02677  PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
       K19662  PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
       K19663  PRKCG; classical protein kinase C gamma type [EC:2.7.11.13]
       K07989  EAT2; EWS/FLI1 activated transcript 2
       K07990  SH2D1A, SAP; SH2 domain protein 1A
       K05132  IFNGR1, CD119; interferon gamma receptor 1
       K05133  IFNGR2; interferon gamma receptor 2
       K05414  IFNA; interferon alpha
       K05415  IFNB; interferon beta
       K05130  IFNAR1; interferon receptor 1
       K05131  IFNAR2; interferon receptor 2
       K04721  TNFSF10, TRAIL; tumor necrosis factor ligand superfamily member 10
       K04722  TNFRSF10, TRAILR; tumor necrosis factor receptor superfamily member 10
       K04389  TNFSF6, FASL; tumor necrosis factor ligand superfamily member 6
       K04390  TNFRSF6, FAS; tumor necrosis factor receptor superfamily member 6
       K01353  GZMB; granzyme B [EC:3.4.21.79]
       K07818  PRF1; perforin 1
       K02187  CASP3; caspase 3 [EC:3.4.22.56]
       K04726  BID; BH3 interacting domain death agonist
     04612 Antigen processing and presentation [PATH:ko04612]
     04660 T cell receptor signaling pathway [PATH:ko04660]
     04662 B cell receptor signaling pathway [PATH:ko04662]
     04664 Fc epsilon RI signaling pathway [PATH:ko04664]
     04666 Fc gamma R-mediated phagocytosis [PATH:ko04666]
     04670 Leukocyte transendothelial migration [PATH:ko04670]
     04672 Intestinal immune network for IgA production [PATH:ko04672]
     04062 Chemokine signaling pathway [PATH:ko04062]
 
   Endocrine system
 
   Circulatory system
 
   Digestive system
 
   Excretory system
 
   Nervous system
 
   Sensory system
 
   Development
 
   Aging
 
   Environmental adaptation
 
 Human Diseases
 
   Cancers
 
   Immune diseases
     05310 Asthma [PATH:ko05310]
     05322 Systemic lupus erythematosus [PATH:ko05322]
     05323 Rheumatoid arthritis [PATH:ko05323]
     05320 Autoimmune thyroid disease [PATH:ko05320]
       K05414  IFNA; interferon alpha
       K06538  CTLA4, CD152; cytotoxic T-lymphocyte-associated protein 4
       K00431  TPO; thyroid peroxidase [EC:1.11.1.8]
       K10809  TG; thyroglobulin
       K06752  MHC2; major histocompatibility complex, class II
       K10784  TRAV; T cell receptor alpha chain V region
       K10785  TRBV; T-cell receptor beta chain V region
       K05412  CD80; CD80 antigen
       K05413  CD86; CD86 antigen
       K06470  CD28; CD28 antigen
       K05429  IL2; interleukin 2
       K06751  MHC1; major histocompatibility complex, class I
       K04389  TNFSF6, FASL; tumor necrosis factor ligand superfamily member 6
       K04390  TNFRSF6, FAS; tumor necrosis factor receptor superfamily member 6
       K07818  PRF1; perforin 1
       K01353  GZMB; granzyme B [EC:3.4.21.79]
       K03161  TNFSF5, CD40L; tumor necrosis factor ligand superfamily member 5
       K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
       K05430  IL4; interleukin 4
       K05428  IL5; interleukin 5
       K05443  IL10, CSIF; interleukin 10
       K06856  IGH; immunoglobulin heavy chain
       K04249  TSHR; thyroid stimulating hormone receptor
       K08522  CGA; glycoprotein hormones, alpha polypeptide
       K05251  TSHB; thyroid stimulating hormone, beta
     05321 Inflammatiory bowel disease (IBD) [PATH:ko05321]
     05330 Allograft rejection [PATH:ko05330]
       K06751  MHC1; major histocompatibility complex, class I
       K10784  TRAV; T cell receptor alpha chain V region
       K10785  TRBV; T-cell receptor beta chain V region
       K05412  CD80; CD80 antigen
       K05413  CD86; CD86 antigen
       K06470  CD28; CD28 antigen
       K05406  IL12A; interleukin 12A
       K05425  IL12B; interleukin 12B
       K04389  TNFSF6, FASL; tumor necrosis factor ligand superfamily member 6
       K04390  TNFRSF6, FAS; tumor necrosis factor receptor superfamily member 6
       K07818  PRF1; perforin 1
       K01353  GZMB; granzyme B [EC:3.4.21.79]
       K06752  MHC2; major histocompatibility complex, class II
       K05429  IL2; interleukin 2
       K03161  TNFSF5, CD40L; tumor necrosis factor ligand superfamily member 5
       K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
       K04687  IFNG; interferon gamma
       K03156  TNFA; tumor necrosis factor superfamily, member 2
       K05430  IL4; interleukin 4
       K05428  IL5; interleukin 5
       K05443  IL10, CSIF; interleukin 10
       K06856  IGH; immunoglobulin heavy chain
     05332 Graft-versus-host disease [PATH:ko05332]
       K05405  IL6; interleukin 6
       K04383  IL1A; interleukin 1 alpha
       K04519  IL1B; interleukin 1 beta
       K03156  TNFA; tumor necrosis factor superfamily, member 2
       K06752  MHC2; major histocompatibility complex, class II
       K10784  TRAV; T cell receptor alpha chain V region
       K10785  TRBV; T-cell receptor beta chain V region
       K05412  CD80; CD80 antigen
       K05413  CD86; CD86 antigen
       K06470  CD28; CD28 antigen
       K05429  IL2; interleukin 2
       K06751  MHC1; major histocompatibility complex, class I
       K04389  TNFSF6, FASL; tumor necrosis factor ligand superfamily member 6
       K04390  TNFRSF6, FAS; tumor necrosis factor receptor superfamily member 6
       K07818  PRF1; perforin 1
       K01353  GZMB; granzyme B [EC:3.4.21.79]
       K04687  IFNG; interferon gamma
       K06516  KLRD1, CD94; killer cell lectin-like receptor subfamily D member 1
     05340 Primary immunodeficiency [PATH:ko05340]
 
   Neurodegenerative diseases
 
   Substance dependence
 
   Cardiovascular diseases
     05410 Hypertrophic cardiomyopathy (HCM) [PATH:ko05410]
     05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) [PATH:ko05412]
     05414 Dilated cardiomyopathy (DCM) [PATH:ko05414]
     05416 Viral myocarditis [PATH:ko05416]
       K06788  CXADR, CAR; coxsackievirus and adenovirus receptor
       K04006  DAF, CD55; decay accelerating factor
       K05703  FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
       K06278  CAV1; caveolin 1
       K06619  ABL1; abelson tyrosine-protein kinase 1 [EC:2.7.10.2]
       K08887  ABL2; abelson tyrosine-protein kinase 2 [EC:2.7.10.2]
       K04392  RAC1; Ras-related C3 botulinum toxin substrate 1
       K07860  RAC2; Ras-related C3 botulinum toxin substrate 2
       K07861  RAC3; Ras-related C3 botulinum toxin substrate 3
       K12563  SGCD; delta-sarcoglycan
       K12564  SGCG; gamma-sarcoglycan
       K12565  SGCA; alpha-sarcoglycan
       K12566  SGCB; beta-sarcoglycan
       K06265  DAG1; dystroglycan 1
       K10366  DMD; dystrophin
       K05692  ACTB_G1; actin beta/gamma 1
       K03260  EIF4G; translation initiation factor 4G
       K04503  CCND1; cyclin D1
       K04398  CASP8; caspase 8 [EC:3.4.22.61]
       K04726  BID; BH3 interacting domain death agonist
       K08738  CYC; cytochrome c
       K04399  CASP9; caspase 9 [EC:3.4.22.62]
       K02187  CASP3; caspase 3 [EC:3.4.22.56]
       K17751  MYH6_7; myosin heavy chain 6/7
       K03161  TNFSF5, CD40L; tumor necrosis factor ligand superfamily member 5
       K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
       K06752  MHC2; major histocompatibility complex, class II
       K10784  TRAV; T cell receptor alpha chain V region
       K10785  TRBV; T-cell receptor beta chain V region
       K06751  MHC1; major histocompatibility complex, class I
       K05412  CD80; CD80 antigen
       K05413  CD86; CD86 antigen
       K06470  CD28; CD28 antigen
       K07818  PRF1; perforin 1
       K05718  ITGAL; integrin alpha L
       K06464  ITGB2; integrin beta 2
       K06490  ICAM1; intercellular adhesion molecule 1
       K06856  IGH; immunoglobulin heavy chain
 
   Endocrine and metabolic diseases
     04930 Type II diabetes mellitus [PATH:ko04930]
     04940 Type I diabetes mellitus [PATH:ko04940]
       K04526  INS; insulin
       K01580  E4.1.1.15, gadB, gadA, GAD; glutamate decarboxylase [EC:4.1.1.15]
       K07817  PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
       K01294  CPE; carboxypeptidase E [EC:3.4.17.10]
       K04077  groEL, HSPD1; chaperonin GroEL
       K19863  ICA1; islet cell auto antigen 1
       K06752  MHC2; major histocompatibility complex, class II
       K05412  CD80; CD80 antigen
       K05413  CD86; CD86 antigen
       K06470  CD28; CD28 antigen
       K05406  IL12A; interleukin 12A
       K05425  IL12B; interleukin 12B
       K05429  IL2; interleukin 2
       K04687  IFNG; interferon gamma
       K06751  MHC1; major histocompatibility complex, class I
       K10784  TRAV; T cell receptor alpha chain V region
       K10785  TRBV; T-cell receptor beta chain V region
       K04389  TNFSF6, FASL; tumor necrosis factor ligand superfamily member 6
       K04390  TNFRSF6, FAS; tumor necrosis factor receptor superfamily member 6
       K07818  PRF1; perforin 1
       K01353  GZMB; granzyme B [EC:3.4.21.79]
       K05468  LTA, TNFB; lymphotoxin alpha (TNF superfamily, member 1)
       K03156  TNFA; tumor necrosis factor superfamily, member 2
       K04383  IL1A; interleukin 1 alpha
       K04519  IL1B; interleukin 1 beta
     04950 Maturity onset diabetes of the young [PATH:ko04950]
     04932 Non-alcoholic fatty liver disease (NAFLD) [PATH:ko04932]
     04931 Insulin resistance [PATH:ko04931]
     04933 AGE-RAGE signaling pathway in diabetic complications [PATH:ko04933]
 
   Infectious diseases
 
   Antimicrobial resistance
 
   Antineoplastic resistance

[ BRITE | KEGG2 | KEGG ]
Last updated: July 27, 2016